How big is the Oral Anti-Diabetic Drugs Market?

The Oral Anti-Diabetic Drugs Market size is expected to reach USD 46.82 billion in 2024 and grow at a CAGR of 4.17% to reach USD 57.44 billion by 2029. Read More

What is the current Oral Anti-Diabetic Drugs Market size?

In 2024, the Oral Anti-Diabetic Drugs Market size is expected to reach USD 46.82 billion. Read More

Who are the key players in Oral Anti-Diabetic Drugs Market?

Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals and AstraZeneca are the major companies operating in the Oral Anti-Diabetic Drugs Market. Read More

Which is the fastest growing region in Oral Anti-Diabetic Drugs Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oral Anti-Diabetic Drugs Market?

In 2024, the Asia-Pacific accounts for the largest market share in Oral Anti-Diabetic Drugs Market. Read More

What years does this Oral Anti-Diabetic Drugs Market cover, and what was the market size in 2023?

In 2023, the Oral Anti-Diabetic Drugs Market size was estimated at USD 44.95 billion. The report covers the Oral Anti-Diabetic Drugs Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oral Anti-Diabetic Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Oral Anti-Diabetic Drugs Companies

This report lists the top Oral Anti-Diabetic Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Oral Anti-Diabetic Drugs industry.